| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lahoud Touma, Alexandra Muccill. Diagnosis and Management of Central Nervous System Demyelinating Disorders. Neurologic clinics. vol 40. issue 1. 2021-11-22. PMID:34798965. |
this article reviews the acute phase assessment and management of these disorders, with a particular focus on multiple sclerosis, neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody disorder, and several atypical demyelinating diseases. |
2021-11-22 |
2023-08-13 |
Not clear |
| Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, Katinka Fischer, Anna Gahlen, Giovanni Novi, Helen Hayward-Könnecke, Sven Schippling, Paulus S Rommer, Barbara Kornek, Tobias Zrzavy, Damien Biotti, Jonathan Ciron, Bertrand Audoin, Achim Berthele, Katrin Giglhuber, Helene Zephir, Tania Kümpfel, Robert Berger, Joachim Röther, Vivien Häußler, Jan-Patrick Stellmann, Daniel Whittam, Anu Jacob, Markus Kraemer, Antoine Gueguen, Romain Deschamps, Antonios Bayas, Martin W Hümmert, Corinna Trebst, Axel Haarmann, Sven Jarius, Brigitte Wildemann, Matthias Grothe, Nadja Siebert, Klemens Ruprecht, Friedemann Paul, Nicolas Collongues, Romain Marignier, Michael Levy, Michael Karenfort, Michael Deppe, Philipp Albrecht, Kerstin Hellwig, Ralf Gold, Hans-Peter Hartung, Sven G Meuth, Ingo Kleiter, Orhan Akta. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurology(R) neuroimmunology & neuroinflammation. vol 9. issue 1. 2021-11-20. PMID:34785575. |
to evaluate the long-term safety and efficacy of tocilizumab (tcz), a humanized anti-interleukin-6 receptor antibody in myelin oligodendrocyte glycoprotein-igg-associated disease (mogad) and neuromyelitis optica spectrum disorders (nmosd). |
2021-11-20 |
2023-08-13 |
Not clear |
| Edgar Carnero Contentti, Pablo A López, Juan Criniti, Juan Pablo Pettinicchi, Edgardo Cristiano, Liliana Patrucco, Elisa Bribiesca Contreras, Enrique Gómez-Figueroa, José Flores-Rivera, Edgar Patricio Correa-Díaz, Ana María Toral Granda, María Angelica Ortiz Yepez, Wilson Alfredo Gualotuña Pachacama, Jefferson Santiago Piedra Andrade, Lorna Galleguillos, Verónica Tkachuk, Debora Nadur, Vanessa Daccach Marques, Ibis Soto de Castillo, Magdalena Casas, Leila Cohen, Ricardo Alonso, Alejandro Caride, Marco Lana-Peixoto, Juan Ignacio Roja. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort. European journal of neurology. 2021-11-20. PMID:34799965. |
chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a latin american cohort. |
2021-11-20 |
2023-08-13 |
Not clear |
| Edgar Carnero Contentti, Pablo A López, Juan Criniti, Juan Pablo Pettinicchi, Edgardo Cristiano, Liliana Patrucco, Elisa Bribiesca Contreras, Enrique Gómez-Figueroa, José Flores-Rivera, Edgar Patricio Correa-Díaz, Ana María Toral Granda, María Angelica Ortiz Yepez, Wilson Alfredo Gualotuña Pachacama, Jefferson Santiago Piedra Andrade, Lorna Galleguillos, Verónica Tkachuk, Debora Nadur, Vanessa Daccach Marques, Ibis Soto de Castillo, Magdalena Casas, Leila Cohen, Ricardo Alonso, Alejandro Caride, Marco Lana-Peixoto, Juan Ignacio Roja. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort. European journal of neurology. 2021-11-20. PMID:34799965. |
optic neuritis (on) is often the initial symptom of neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein-associated disease (mogad). |
2021-11-20 |
2023-08-13 |
Not clear |
| Laura Clarke, Simon Arnett, Kate Lilley, Jacky Liao, Sandeep Bhuta, Simon A Broadle. Magnetic resonance imaging in neuromyelitis optica spectrum disorder. Clinical and experimental immunology. vol 206. issue 3. 2021-11-09. PMID:34080180. |
neuromyelitis optica spectrum disorder (nmosd) is an inflammatory disease of the central nervous system (cns) associated with antibodies to aquaporin-4 (aqp4), which has distinct clinical, radiological and pathological features, but also has some overlap with multiple sclerosis and myelin oligodendrocyte glycoprotein (mog) antibody associated disease. |
2021-11-09 |
2023-08-13 |
Not clear |
| Frederik Bartels, Angelo Lu, Frederike Cosima Oertel, Carsten Finke, Friedemann Paul, Claudia Chie. Clinical and neuroimaging findings in MOGAD-MRI and OCT. Clinical and experimental immunology. vol 206. issue 3. 2021-11-09. PMID:34152000. |
clinical and neuroimaging findings in mogad-mri and oct. myelin oligodendrocyte glycoprotein antibody-associated disorders (mogad) are rare in both children and adults, and have been recently suggested to be an autoimmune neuroinflammatory group of disorders that are different from aquaporin-4 autoantibody-associated neuromyelitis optica spectrum disorder and from classic multiple sclerosis. |
2021-11-09 |
2023-08-13 |
Not clear |
| Hannah H Zhao-Fleming, Cristina Valencia Sanchez, Elia Sechi, Jery Inbarasu, Eelco F Wijdicks, Sean J Pittock, John J Chen, Dean M Wingerchuk, Brian G Weinshenker, Sebastian Lopez-Chiriboga, Divyanshu Dubey, Jan-Mendelt Tillema, Michel Toledano, Hemang Yadav, Eoin P Flanaga. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. vol 97. issue 13. 2021-10-29. PMID:34389648. |
severe attacks of myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) and aquaporin-4 (aqp4) antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) may require ventilatory support, but data on episodes are limited, particularly for mogad. |
2021-10-29 |
2023-08-13 |
Not clear |
| Devon A Cohen, Ryan Gise, Eric D Gaie. Serum Biomarkers in Neuro-Ophthalmology: When to Test. Seminars in ophthalmology. vol 36. issue 4. 2021-10-28. PMID:33689572. |
the utility of select biomarkers for myasthenia gravis, neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein-igg-associated disorder, opsoclonus-myoclonus syndrome, anti-collapsin-response mediator protein-5 optic neuropathy, and glial fibrillary acidic protein-igg-associated disease are discussed with particular focus on the clinical contexts in which to consider testing. |
2021-10-28 |
2023-08-13 |
Not clear |
| Tetsuya Akaishi, Noriko Himori, Takayuki Takeshita, Tatsuro Misu, Toshiyuki Takahashi, Yoshiki Takai, Shuhei Nishiyama, Juichi Fujimori, Tadashi Ishii, Masashi Aoki, Kazuo Fujihara, Toru Nakazawa, Ichiro Nakashim. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease. Multiple sclerosis and related disorders. vol 56. 2021-10-26. PMID:34461572. |
optic neuritis (on) is a major phenotype of clinical attack related to demyelinating neurological diseases of the central nervous system, including multiple sclerosis (ms), anti-aquaporin-4 (aqp4) antibody-positive neuromyelitis optica spectrum disorder (nmosd), and anti-myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2021-10-26 |
2023-08-13 |
Not clear |
| Anna Presicci, Maria Serra, Mariaclara Achille, Elvita Caputo, Lucia Margar. Pediatric Optic Neuritis: Description of Four Cases and Review of the Literature. Children (Basel, Switzerland). vol 8. issue 10. 2021-10-26. PMID:34682120. |
pon has a high impact on the quality of life as it may or may not evolve into other acquired demyelinating syndromes (adss), such as multiple sclerosis (ms), neuromyelitis optica (nmo), or other syndromes related to the myelin oligodendrocyte glycoprotein igg antibodies (mog-igg). |
2021-10-26 |
2023-08-13 |
Not clear |
| Ryuji Sakakibar. Gastrointestinal dysfunction in neuroinflammatory diseases: Multiple sclerosis, neuromyelitis optica, acute autonomic ganglionopathy and related conditions. Autonomic neuroscience : basic & clinical. vol 232. 2021-10-25. PMID:33740560. |
among such cns diseases are multiple sclerosis, neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein associated disorder, and autoimmune encephalitis. |
2021-10-25 |
2023-08-13 |
Not clear |
| Edgar Carnero Contentti, Pablo A López, Juan Ignacio Roja. The frequency of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-IgG-negative neuromyelitis optica spectrum disorders patients in Latin America. Multiple sclerosis and related disorders. vol 54. 2021-10-15. PMID:34246022. |
the frequency of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-igg-negative neuromyelitis optica spectrum disorders patients in latin america. |
2021-10-15 |
2023-08-13 |
Not clear |
| Ting-Yi Lin, Claudia Chien, Angelo Lu, Friedemann Paul, Hanna G Zimmerman. Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review. Expert review of neurotherapeutics. vol 21. issue 10. 2021-10-13. PMID:34551653. |
neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein igg antibody-associated disorders (mogad) comprise two groups of rare neuroinflammatory diseases that cause attack-related damage to the central nervous system (cns). |
2021-10-13 |
2023-08-13 |
Not clear |
| Florence Pache, Marius Ringelstein, Orhan Aktas, Ingo Kleiter, Sven Jarius, Nadja Siebert, Judith Bellmann-Strobl, Friedemann Paul, Klemens Ruprech. C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD. Journal of neuroimmunology. vol 360. 2021-10-11. PMID:34464830. |
while complement-dependent cytotoxicity (cdc) is a known effector mechanism in aquaporin-4-immunoglobulin (ig)g-positive (aqp4-igg+) neuromyelitis optica spectrum disorder (nmosd), the role of cdc in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is less clear. |
2021-10-11 |
2023-08-13 |
Not clear |
| Negar Molazadeh, Angeliki G Filippatou, Eleni S Vasileiou, Michael Levy, Elias S Sotircho. Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder. Journal of neuroimmunology. vol 360. 2021-10-11. PMID:34547512. |
myelin oligodendrocyte glycoprotein antibody disease (mogad) and aquaporin-4 igg seropositive neuromyelitis optica spectrum disorder (aqp4-igg+ nmosd) are generally considered to be relapsing disorders, without clinical progression or subclinical disease activity outside of clinical relapses, in contrast to multiple sclerosis (ms). |
2021-10-11 |
2023-08-13 |
Not clear |
| Elia Sechi, Karl N Krecke, Steven A Messina, Marina Buciuc, Sean J Pittock, John J Chen, Brian G Weinshenker, A Sebastian Lopez-Chiriboga, Claudia F Lucchinetti, Nicholas L Zalewski, Jan Mendelt Tillema, Amy Kunchok, Salvatore Monaco, Padraig P Morris, James P Fryer, Adam Nguyen, Tammy Greenwood, Stephanie B Syc-Mazurek, B Mark Keegan, Eoin P Flanaga. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. vol 97. issue 11. 2021-10-05. PMID:34261784. |
we sought to compare mri t2 lesion evolution in myelin oligodendrocyte glycoprotein immunoglobulin g (igg)-associated disorder (mogad), aquaporin 4 igg-positive neuromyelitis optica spectrum disorder (aqp4-igg-nmosd), and multiple sclerosis (ms). |
2021-10-05 |
2023-08-13 |
Not clear |
| Meng-Ting Cai, Yang Zheng, Chun-Hong Shen, Fan Yang, Wei Fang, Yin-Xi Zhang, Mei-Ping Din. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder. Multiple sclerosis (Houndmills, Basingstoke, England). vol 27. issue 6. 2021-09-24. PMID:32672091. |
to validate the recently proposed imaging criteria in distinguishing aquaporin-4 antibody (aqp4-ab)-seropositive neuromyelitis optica spectrum disorder (nmosd) from multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein antibody-associated disorder (mog-ad) at disease onset in a chinese population. |
2021-09-24 |
2023-08-13 |
Not clear |
| Aaron Winter, Bart Chwalis. MRI Characteristics of NMO, MOG and MS Related Optic Neuritis. Seminars in ophthalmology. vol 35. issue 7-8. 2021-09-23. PMID:33395326. |
acute isolated optic neuritis can be the initial presentation of demyelinating inflammatory central nervous system disease related to multiple sclerosis (ms), neuromyelitis optica (nmo) or myelin oligodendrocyte glycoprotein antibody disease (mog-ad). |
2021-09-23 |
2023-08-13 |
Not clear |
| Céline Louapre, Elisabeth Maillart, Caroline Papeix, Sinead Zeidan, Damien Biotti, Zoé Lepine, Abir Wahab, Mickael Zedet, Pierre Labauge, Caroline Tilikete, Julie Pique, Ayman Tourbah, Guillaume Mathey, Dalia Dimitri Boulos, Pierre Branger, Laurent Daniel Kremer, Romain Marignier, Nicolas Collongues, Jérôme De Sez. Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. European journal of neurology. vol 28. issue 10. 2021-09-21. PMID:33103295. |
outcomes of coronavirus disease 2019 (covid-19) in patients with neuromyelitis optica spectrum disorders (nmosd) or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), often treated with immunosuppressive therapies, are still unknown. |
2021-09-21 |
2023-08-13 |
Not clear |
| Amanda Marchionatti, Gisele Hansel, Gabriela Urbanski Avila, Douglas Kazutoshi Sat. Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry. Frontiers in immunology. vol 12. 2021-09-20. PMID:34025652. |
human antibodies against myelin oligodendrocyte glycoprotein (mog) from immunoglobulin-g subclasses (mog-igg) have been recently associated with a new subgroup of neurological autoimmune diseases with distinct clinical characteristics from multiple sclerosis and neuromyelitis optica spectrum disorders. |
2021-09-20 |
2023-08-13 |
human |